ZOONF fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Zoono Group Ltd. is a pharmaceutical and biotechnology company, which engages in the development, manufacture, and sale of antimicrobial technology effective against pathogens including bacteria, viruses, mould, algae, and fungi. The firm operates through the following geographical segments: Australasia, Asia, US, India, UK, and Europe. Its products include hand sanitiser, textile applicator, mould remediation, and surface sanitiser. The company was founded by Paul Hyslop in 2007 and is headquartered in Auckland, New Zealand.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
ZOONF has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company